On Friday evening, December 18, 2020, the United States Food and Drug Administration (FDA) approved Moderna’s mRNA COVID-19 vaccine for emergency use, joining Pfizer’s previously approved vaccine in the fight against COVID-19. In previous articles, I...
There are few areas in healthcare more promising than genetics. As genetic testing becomes a more integral part of routine care, it is vital that physicians understand the best way to communicate the findings accurately and compassionately with patients. Enter genetic...
On Friday, December 12, 2020, the United States Food and Drug Administration issued its first Emergency Use Authorization for a COVID-19 vaccine. The FDA’s approval of this vaccine, developed by Pfizer, followed recent approvals of the same vaccine by the UK,...
Pfizer and Moderna grabbed headlines, and ushered in hope, in announcing this month that each company has vaccines that preliminary data suggest being 90-94% effective in preventing COVID-19 infections. This news is a much-needed salve to a world that has surpassed...
November is Lung Cancer Awareness Month. According to the Centers for Disease Control and Prevention (CDC), lung cancer is the leading cause of cancer death and the second most common cancer among both men and women in the United States. On top of those jarring...
